Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Evidence base remains poor for botulinum toxin injections, Cochrane review researchers conclude

The efficacy of using intravesical botulinum toxin to treat overactive bladder syndrome is supported by little more than anecdotal evidence and case reports, according a Cochrane review. In addition, the optimal dose of botulinum toxin for efficacy and safety has not been identified.

Subscribe for full online access and get...

  • Full, instant access to all stories
  • Customised email alerts straight to your inbox
  • 5,000+ practice articles in our clinical archive
  • Online learning units on fundamental aspects of nursing care

Register for guest access to keep reading and get..

  • A free taste of other selected news stories
  • Daily email newsletters
  • 5,000+ practice articles in our clinical archive
  • Online learning units on fundamental aspects of nursing care

Speak with a member of the team about providing Nursing Times for your whole team
Are you a student nurse? Take advantage of a discounted rate by clicking here (Graduation date required)
Already have an account? Sign in